EP3031460 - BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.05.2021 Database last updated on 13.11.2024 | |
Former | Examination is in progress Status updated on 26.01.2018 | ||
Former | Request for examination was made Status updated on 23.12.2016 | Most recent event Tooltip | 21.05.2021 | Application deemed to be withdrawn | published on 23.06.2021 [2021/25] | Applicant(s) | For all designated states Cempra Pharmaceuticals Inc. 6320 Quadrangle Drive Suite 360 Chapel Hill, NC 27517 / US | [2016/24] | Inventor(s) | 01 /
Fernandes, Prabhavathi, B. 114 Milton Avenue Chapel Hill, NC North Carolina 27514 / US | [2016/24] | Representative(s) | Elsy, David Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [N/P] |
Former [2016/24] | Elsy, David Withers & Rogers LLP 4 More London Riverside London SE1 2AU / GB | Application number, filing date | 15186676.1 | 24.10.2009 | [2016/24] | Priority number, date | US20080108137P | 24.10.2008 Original published format: US 108137 P | US20080108110P | 24.10.2008 Original published format: US 108110 P | US20080108168P | 24.10.2008 Original published format: US 108168 P | US20080108112P | 24.10.2008 Original published format: US 108112 P | US20080108134P | 24.10.2008 Original published format: US 108134 P | US20090162109P | 20.03.2009 Original published format: US 162109 P | [2016/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3031460 | Date: | 15.06.2016 | Language: | EN | [2016/24] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 03.05.2016 | Classification | IPC: | A61K31/70, A61K31/04, A61K31/7052, A61P31/00 | [2016/24] | CPC: |
A61K31/7048 (EP,US);
A61K31/7056 (EP,CN,US);
A61K31/424 (EP,US);
A61K31/70 (EP,US);
A61K31/7052 (EP,US);
A61K31/706 (CN);
A61P1/00 (EP);
A61P1/04 (EP);
A61P11/00 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P33/02 (EP);
C07D498/04 (EP,US);
C07H17/08 (EP,US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2017/04] |
Former [2016/24] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | BIOABWEHR UNTER VERWENDUNG TRIAZOLHALTIGER MAKROLIDE | [2016/24] | English: | BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES | [2016/24] | French: | BIODÉFENSES UTILISANT DES MACROLIDES CONTENANT DES TRIAZOLES | [2016/24] | Examination procedure | 24.09.2015 | Date on which the examining division has become responsible | 14.12.2016 | Amendment by applicant (claims and/or description) | 14.12.2016 | Examination requested [2017/04] | 25.01.2018 | Despatch of a communication from the examining division (Time limit: M06) | 02.08.2018 | Reply to a communication from the examining division | 08.02.2019 | Despatch of a communication from the examining division (Time limit: M06) | 22.11.2019 | Reply to a communication from the examining division | 17.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 28.01.2021 | Application deemed to be withdrawn, date of legal effect [2021/25] | 17.02.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/25] | Parent application(s) Tooltip | EP09822828.1 / EP2358379 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 22.11.2019 | Request for further processing filed | 22.11.2019 | Full payment received (date of receipt of payment) Request granted | 03.12.2019 | Decision despatched | Fees paid | Renewal fee | 24.09.2015 | Renewal fee patent year 03 | 24.09.2015 | Renewal fee patent year 04 | 24.09.2015 | Renewal fee patent year 05 | 24.09.2015 | Renewal fee patent year 06 | 24.09.2015 | Renewal fee patent year 07 | 19.10.2016 | Renewal fee patent year 08 | 30.10.2017 | Renewal fee patent year 09 | 24.10.2018 | Renewal fee patent year 10 | 30.04.2020 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 31.10.2019 | 11   M06   Fee paid on   30.04.2020 | 31.10.2020 | 12   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2003176327 (CASSELL GAIL HOUSTON [US], et al) [A] 1-13* the whole document *; | [AD]US2006100164 (LIANG CHANG-HSING [US], et al) [AD] 1-13 * the whole document *; | [A] - LIANG C H ET AL, "Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 15, no. 5, doi:10.1016/J.BMCL.2005.01.027, ISSN 0960-894X, (20050301), pages 1307 - 1310, (20050301), XP025314537 [A] 1-13 * figures 3, 4; table 1 * DOI: http://dx.doi.org/10.1016/j.bmcl.2005.01.027 | by applicant | US2006100164 | WO2009055557 | - DRUSANO ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERASPY, (200811), vol. 52, no. 11, pages 3973 - 3979 | - INGLESBY ET AL., JAMA, (2002), vol. 287, no. 17, pages 2236 - 2252 | - LEMAIRE ET AL., ANTIMICROB. AGENTS. CHEMOTHER., (2009), vol. 53, pages 3734 - 3743 | - AAC, (2006), vol. 50, pages 841 - 51 | - AAC, (2007), vol. 51, pages 2748 - 57 | - AAC, (2006), vol. 50, pages 841 - 851 | - BARCIA-MACAY ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2006), vol. 50, pages 841 - 851 | - BARCIA-MACAY ET AL., "Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages Antimicrob", AGENTS CHEMOTHER., (2006), vol. 50, pages 841 - 851 |